Deals
Merck KGaA to Buy Sigma-Aldrich for to Add Chemicals
This article is for subscribers only.
Merck KGaA agreed to buy Sigma-Aldrich Corp. for $17 billion in cash to expand in chemicals used in research labs and pharmaceutical manufacturing and reduce its dependence on drug development.
Merck will pay $140 a share, 37 percent more than Sigma-Aldrich’s closing price on Sept. 19, the Darmstadt, Germany-based company said in a statement today. St. Louis-based Sigma-Aldrich will add to Merck’s earnings immediately, according to the statement. Merck’s shares jumped the most in more than nine months in Frankfurt.